Department of Dermatology - Open Access Policy Deposits

eScholarship stats: History by Item for March through June, 2026

Item	Title	Total requests	2026-06	2026-05	2026-04	2026-03
3nk5r7mw	Topical Management of Pediatric Psoriasis: A Review of New Developments and Existing Therapies	628	34	517	48	29
0zf2s1cf	Seborrheic Dermatitis: Exploring the Complex Interplay with Malassezia	599	142	172	161	124
3455571b	Amitriptyline-induced cutaneous hyperpigmentation: case report and review of psychotropic drug-associated mucocutaneous hyperpigmentation	534	128	141	133	132
02k9z6qd	Isotretinoin and Timing of Procedural Interventions: A Systematic Review With Consensus Recommendations	452	130	132	91	99
1rd5q5tz	Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis	404	97	93	136	78
5r79d67k	Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: report of a case and review of the literature	352	66	127	75	84
08j6337f	Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris	335	141	77	67	50
62d7n4g9	Designing a broad-spectrum integrative approach for cancer prevention and treatment	335	36	102	110	87
47q8p2w7	Nevoid melanoma and eruptive nevi from erlotinib	306	64	104	63	75
0793n5z2	Isotretinoin therapy for the treatment of acne in patients with cystic fibrosis: a case series and review of the literature	305	68	97	73	67
47p4d8zv	Penicillamine-associated cutis laxa and milia en plaque - case report and review of cutaneous changes associated with penicillamine	291	54	105	62	70
25q9w6r9	Dupilumab for bullous pemphigoid with intractable pruritus	281	50	87	77	67
1xf7w7x4	Characteristics of research tracks in dermatology residency programs: a national survey	276	65	74	75	62
2dn263n7	Skin neurogenic inflammation	273	72	90	70	41
5xs3g48j	Acne and Rosacea	272	42	102	78	50
2vz565gs	Competition between skin antimicrobial peptides and commensal bacteria in type 2 inflammation enables survival of S. aureus	268	68	86	58	56
8p66q9fv	Pleomorphic dermal sarcoma in a man with HIV: report with next-generation sequencing analysis and review of the atypical fibroxanthoma/pleomorphic dermal sarcoma spectrum	267	45	90	64	68
8z66m3xd	Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial	266	78	78	61	49
2qr3w771	Urgent safety considerations for dermatologic surgeons in the COVID-19 pandemic	265	43	98	67	57
0220n292	Dermal white adipose tissue: a new component of the thermogenic response	264	63	82	65	54
0sg0z14s	Genitogluteal porokeratosis in an HIV-positive man: a case report and review of the literature on genital porokeratosis	264	39	88	66	71
0n77t015	Lymphomatoid papulosis in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma: case report and literature review	255	35	101	62	57
5c88q182	Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition	251	104	64	45	38
2800q59v	TREM2 macrophages induced by human lipids drive inflammation in acne lesions	250	60	76	62	52
216788xg	Safety and Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis: A 52-Week, Open-Label, Phase 3 Study	247	86	76	41	44
5kk7h8hg	Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Study	247	67	61	63	56
6hz8s1mh	Eccrine chromhidrosis secondary to hyperbilirubinemia	245	48	82	67	48
55q795hc	Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis	243	64	60	71	48
9t16k3hw	Evaluation of stenoses using AI video models applied to coronary angiography	238	63	69	52	54
7bx0q1dh	Polygenic prediction of atopic dermatitis improves with atopic training and filaggrin factors	233	84	57	49	43
1rw3692c	Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6–11 Years of Age with Severe Atopic Dermatitis	232	64	56	56	56
44q8g6b8	Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS).	232	51	80	61	40
2xn7z5c4	Botulinum toxin blocks mast cells and prevents rosacea like inflammation	231	59	58	65	49
6t87g6qr	The Ubiquitous Human Skin Commensal Staphylococcus hominis Protects against Opportunistic Pathogens	229	53	90	50	36
69s5d7c2	Short-Chain Fatty Acids from Cutibacterium acnes Activate Both a Canonical and Epigenetic Inflammatory Response in Human Sebocytes	227	50	62	64	51
25j8m068	Antimicrobial production by perifollicular dermal preadipocytes is essential to the pathophysiology of acne	226	60	78	49	39
3m85j4j2	DNA fragmentation factor B suppresses interferon to enable cancer persister cell regrowth	224	66	55	65	38
1bk078v9	Narrative review on the management of moderate-severe atopic dermatitis in pediatric age of the Italian Society of Pediatric Allergology and Immunology (SIAIP), of the Italian Society of Pediatric Dermatology (SIDerP) and of the Italian Society of Pediatrics (SIP)	222	38	45	62	77
1h87c6v1	S. aureus drives itch and scratch-induced skin damage through a V8 protease-PAR1 axis	222	48	54	59	61
0qh4v88r	Mast Cell Degranulation and Fibroblast Activation in the Morphine-induced Spinal Mass: Role of Mas-related G Protein-coupled Receptor Signaling.	220	32	91	43	54
6bd758q1	Dermal injury drives a skin to gut axis that disrupts the intestinal microbiome and intestinal immune homeostasis in mice	220	57	48	70	45
21z823s5	The transcription elongation factors Spt4 and Spt6 promote dermal adipocyte differentiation	217	22	72	123
3kf444c9	Commensal Cutibacterium acnes induce epidermal lipid synthesis important for skin barrier function	216	53	72	46	45
38g465s4	Staphylococcus epidermidis protease EcpA can be a deleterious component of the skin microbiome in atopic dermatitis	214	47	60	58	49
68c7v95d	Consensus Statement for the Management and Treatment of Port-Wine Birthmarks in Sturge-Weber Syndrome	214	46	40	67	61
22t2148g	Practical Management of the JAK1 Inhibitor Abrocitinib for Atopic Dermatitis in Clinical Practice: Special Safety Considerations	212	49	84	44	35
85m1b2b9	The microbiome in patients with atopic dermatitis	211	83	52	41	35
39n4p5d6	Continuity of care in dermatology residency programs in the United States	210	32	73	57	48
9xk8c429	Diaper dermatitis prevalence and severity: Global perspective on the impact of caregiver behavior	210	44	62	50	54
49f6450d	Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris	208	56	72	45	35

Top

Note: Due to the evolving nature of web traffic, the data presented here should be considered approximate and subject to revision. Learn more.